本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Compugen醫療

2.46
-0.0050-0.20%
成交量:4.38萬
成交額:10.80萬
市值:2.32億
市盈率:6.58
高:2.49
開:2.47
低:2.45
收:2.46
52周最高:3.24
52周最低:1.30
股本:9,455.41萬
流通股本:9,245.75萬
量比:0.36
換手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):0.3733
每股收益(LYR):0.3783
淨資產收益率:50.64%
總資產收益率:15.46%
市淨率:2.62
市盈率(LYR):6.49

資料載入中...

2020/03/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/24

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/20

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/06

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/08

SEC問詢函

[Cover]Correspondence